重大事件
即時報告
8-K
2026-06-03
總結：8-K屬於常規FD披露，亮點在於隨附的投資者簡報；無即時業績數字，重點應放在公司對未來業務展望的表述上。
AI 繁中摘要
Turn Therapeutics（股票代碼：TTRX）於2026年6月3日提交了一份8-K現行報告，主要涉及兩項披露：Item 7.01（Regulation FD披露）及Item 9.01（財務報表及附件）。同日公司還發布了一份投資者簡報（EX-99.1），作為附件一併提交。📄
雖然該8-K並未包含具體財務業績數字，但從簡報的推出時機來看，市場普遍預期公司可能在更新其臨床開發進程或業務發展策略。Turn Therapeutics專注於藥物製劑領域，本次披露或與旗下候選藥物的最新進展有關。🔬
值得注意的是，本次報告未提及任何重大最終協議、融資安排或監管批准結果，因此短期內對股價的直接影響相對有限。投資者應密切關注後續發布的完整簡報內容，以評估公司研發管線的里程碑進度及資本配置方向。📊
總結：8-K屬於常規FD披露，亮點在於隨附的投資者簡報；無即時業績數字，重點應放在公司對未來業務展望的表述上。⚠️
展開英文正文
EDGAR Filing Documents for 0001213900-26-064405 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-064405 Filing Date 2026-06-03 Accepted 2026-06-03 06:12:38 Documents 40 Period of Report 2026-06-03 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0293128-8k_turn.htm iXBRL 8-K 26320 2 INVESTOR PRESENTATION, DATED JUNE 3, 2026 ea029312801ex99-1.htm EX-99.1 36314 3 GRAPHIC ea029312801_ex99-1img1.jpg GRAPHIC 715946 4 GRAPHIC ea029312801_ex99-1img2.jpg GRAPHIC 1667966 5 GRAPHIC ea029312801_ex99-1img3.jpg GRAPHIC 1074245 6 GRAPHIC ea029312801_ex99-1img4.jpg GRAPHIC 890990 7 GRAPHIC ea029312801_ex99-1img5.jpg GRAPHIC 506587 8 GRAPHIC ea029312801_ex99-1img6.jpg GRAPHIC 540060 9 GRAPHIC ea029312801_ex99-1img7.jpg GRAPHIC 688919 10 GRAPHIC ea029312801_ex99-1img8.jpg GRAPHIC 622434 11 GRAPHIC ea029312801_ex99-1img9.jpg GRAPHIC 641888 12 GRAPHIC ea029312801_ex99-1img10.jpg GRAPHIC 544506 13 GRAPHIC ea029312801_ex99-1img11.jpg GRAPHIC 523164 14 GRAPHIC ea029312801_ex99-1img12.jpg GRAPHIC 320464 15 GRAPHIC ea029312801_ex99-1img13.jpg GRAPHIC 341046 16 GRAPHIC ea029312801_ex99-1img14.jpg GRAPHIC 465861 17 GRAPHIC ea029312801_ex99-1img15.jpg GRAPHIC 526692 18 GRAPHIC ea029312801_ex99-1img16.jpg GRAPHIC 484743 19 GRAPHIC ea029312801_ex99-1img17.jpg GRAPHIC 987108 20 GRAPHIC ea029312801_ex99-1img18.jpg GRAPHIC 635925 21 GRAPHIC ea029312801_ex99-1img19.jpg GRAPHIC 348466 22 GRAPHIC ea029312801_ex99-1img20.jpg GRAPHIC 776547 23 GRAPHIC ea029312801_ex99-1img21.jpg GRAPHIC 816782 24 GRAPHIC ea029312801_ex99-1img22.jpg GRAPHIC 680162 25 GRAPHIC ea029312801_ex99-1img23.jpg GRAPHIC 555306 26 GRAPHIC ea029312801_ex99-1img24.jpg GRAPHIC 671381 27 GRAPHIC ea029312801_ex99-1img25.jpg GRAPHIC 365921 28 GRAPHIC ea029312801_ex99-1img26.jpg GRAPHIC 810183 29 GRAPHIC ea029312801_ex99-1img27.jpg GRAPHIC 905099 30 GRAPHIC ea029312801_ex99-1img28.jpg GRAPHIC 714936 Complete submission text file 0001213900-26-064405.txt 26166837 Data Files Seq Description Document Type Size 31 XBRL SCHEMA FILE ttrx-20260603.xsd EX-101.SCH 3038 32 XBRL LABEL FILE ttrx-20260603_lab.xml EX-101.LAB 34239 33 XBRL PRESENTATION FILE ttrx-20260603_pre.xml EX-101.PRE 22374 43 EXTRACTED XBRL INSTANCE DOCUMENT ea0293128-8k_turn_htm.xml XML 3215 Mailing Address 250 N. WESTLAKE BLVD. WESTLAKE VILLAGE CA Business Address 250 NORTH WESTLAKE BLVD. #210 WESTLAKE VILLAGE CA 91362 8185644011 Turn Therapeutics Inc. (Filer) CIK: 0002023016 (see all company filings) EIN.: 320456090 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-42875 | Film No.: 261058823 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)